These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20856798)

  • 61. Cost effectiveness of a targeted age-based West Nile virus vaccination program.
    Shankar MB; Staples JE; Meltzer MI; Fischer M
    Vaccine; 2017 May; 35(23):3143-3151. PubMed ID: 28456529
    [TBL] [Abstract][Full Text] [Related]  

  • 62. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Kroger AT; Atkinson WL; Marcuse EK; Pickering LK;
    MMWR Recomm Rep; 2006 Dec; 55(RR-15):1-48. PubMed ID: 17136024
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Vaccination rate of premature infants at 6 and 24 months of age: a pilot study].
    Pinquier D; Adde-Michela C; Ploin D; Levêque C; Marret S;
    Arch Pediatr; 2009 Dec; 16(12):1533-9. PubMed ID: 19854629
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immunisation coverage, 2012.
    Hull BP; Dey A; Menzies RI; Brotherton JM; McIntyre PB
    Commun Dis Intell Q Rep; 2014 Sep; 38(3):E208-31. PubMed ID: 25391407
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Incorporating herd immunity effects into cohort models of vaccine cost-effectiveness.
    Bauch CT; Anonychuk AM; Van Effelterre T; Pham BZ; Merid MF
    Med Decis Making; 2009; 29(5):557-69. PubMed ID: 19605882
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.
    Hennessey KA; Ion-Nedelcu N; Craciun MD; Toma F; Wattigney W; Strebel PM
    Am J Epidemiol; 1999 Dec; 150(11):1250-7. PubMed ID: 10588086
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A postpartum vaccination promotion intervention using motivational interviewing techniques improves short-term vaccine coverage: PromoVac study.
    Gagneur A; Lemaître T; Gosselin V; Farrands A; Carrier N; Petit G; Valiquette L; De Wals P
    BMC Public Health; 2018 Jun; 18(1):811. PubMed ID: 29954370
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim.
    Megiddo I; Colson AR; Nandi A; Chatterjee S; Prinja S; Khera A; Laxminarayan R
    Vaccine; 2014 Aug; 32 Suppl 1():A151-61. PubMed ID: 25091670
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Update on universal annual influenza immunization recommendations for children.
    Bekker A; Chou C; Bernstein HH
    Curr Opin Pediatr; 2009 Feb; 21(1):122-6. PubMed ID: 19242248
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vaccine-related adverse events in Cuban children, 1999-2008.
    Galindo BM; Concepción D; Galindo MA; Pérez A; Saiz J
    MEDICC Rev; 2012 Jan; 14(1):38-43. PubMed ID: 22334111
    [TBL] [Abstract][Full Text] [Related]  

  • 72. EPI immunization coverage, timeliness and dropout rate among children in a West Cameroon health district: a cross sectional study.
    Ateudjieu J; Yakum MN; Goura AP; Tembei AM; Ingrid DK; Bita'a Landry B; Kenfack B; Amada L; Tadzong I; Bissek AC
    BMC Public Health; 2020 Feb; 20(1):228. PubMed ID: 32054484
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The impact of new universal child influenza programs in Australia: Vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018.
    Blyth CC; Cheng AC; Crawford NW; Clark JE; Buttery JP; Marshall HS; Francis JR; McRae J; Kotsimbos T; Kelly PM; Macartney KK;
    Vaccine; 2020 Mar; 38(13):2779-2787. PubMed ID: 32107062
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Voluntary vaccination dilemma with evolving psychological perceptions.
    Feng X; Wu B; Wang L
    J Theor Biol; 2018 Feb; 439():65-75. PubMed ID: 29199090
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A mathematical model of hepatitis a transmission in the United States indicates value of universal childhood immunization.
    Van Effelterre TP; Zink TK; Hoet BJ; Hausdorff WP; Rosenthal P
    Clin Infect Dis; 2006 Jul; 43(2):158-64. PubMed ID: 16779741
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Optimising age coverage of seasonal influenza vaccination in England: A mathematical and health economic evaluation.
    Hill EM; Petrou S; Forster H; de Lusignan S; Yonova I; Keeling MJ
    PLoS Comput Biol; 2020 Oct; 16(10):e1008278. PubMed ID: 33021983
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Vaccination coverage among children enrolled in Head Start programs or day care facilities or entering school.
    Jiles RB; Fuchs C; Klevens RM
    MMWR CDC Surveill Summ; 2000 Sep; 49(9):27-38. PubMed ID: 11016876
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunization of children with secondary immunodeficiency.
    Esposito S; Prada E; Lelii M; Castellazzi L
    Hum Vaccin Immunother; 2015; 11(11):2564-70. PubMed ID: 26176360
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vaccination Coverage Among Children Aged 19-35 Months - United States, 2016.
    Hill HA; Elam-Evans LD; Yankey D; Singleton JA; Kang Y
    MMWR Morb Mortal Wkly Rep; 2017 Nov; 66(43):1171-1177. PubMed ID: 29095807
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Change in hepatitis A epidemiology after vaccinating high risk children in Taiwan, 1995-2008.
    Tsou TP; Liu CC; Huang JJ; Tsai KJ; Chang HF
    Vaccine; 2011 Apr; 29(16):2956-61. PubMed ID: 21329774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.